latest update:
[TrialBase DB]

trial summary · NCT07659678

CCR2 PET Imaging Head and Neck Squamous Cell Carcinoma

Trial record from the TrialBase DB dataset, status RECRUITING, condition Head and Neck Squamous Cell Carcinoma, sponsored by Washington University School of Medicine. Facts below are exported values from the current release, not inferred or edited prose.

registry NCT07659678phase PHASE2enrollment 90start 2026-10-31

Summary

The brief summary is the registry's published description, capped for length. Field definitions, types, and provenance rules are in the data dictionary.

This is a prospective study to evaluate the sensitivity and specificity of Cu-64 DOTA-ECL1i PET/CT imaging to serve as a novel precision imaging tool for patients with head and neck squamous cell carcinoma (HNSCC).

Source record: https://clinicaltrials.gov/study/NCT07659678

Facts

registry idNCT07659678
primary registryclinicaltrials-gov
recruitment statusRECRUITING
phasePHASE2
study typeINTERVENTIONAL
lead conditionHead and Neck Squamous Cell Carcinoma
sponsorWashington University School of Medicine
sponsor classOTHER
enrollment90
start date2026-10-31
primary completion2032-05-31
completion2032-05-31
results postednot reported

Conditions

  • Head and Neck Squamous Cell Carcinoma
  • Head and Neck Squamous Cell Carcinoma (HNSCC) - Recurrent/Metastatic (R/M)
  • Head and Neck Squamous Cell Carcinoma HNSCC

Interventions

  • 64Cu-DOTA-ECL1i

Countries

  • United States

Intervention types: DRUG

Work with this record